PMGC HOLDINGS INC. Debt Securities, Trading, Unrealized Gain
PMGC HOLDINGS INC. (ELAB) reported Debt Securities, Trading, Unrealized Gain of $182.59 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesTradingUnrealizedGain · last filed 2025-08-13
- PMGC HOLDINGS INC. debt securities, trading, unrealized gain for the quarter ending 2025-06-30 was $131.30K.
- PMGC HOLDINGS INC. debt securities, trading, unrealized gain for the quarter ending 2025-03-31 was $51.30K.
| Period end | Debt Securities, Trading, Unrealized Gain 3 month | Debt Securities, Trading, Unrealized Gain 6 month |
|---|---|---|
| 2025-06-30 | $131.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $182.59K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $51.30K 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |